Advanced sequencing technology for cancer analysis
Fourth-Generation Nanopore-Assisted Sequencing for Advanced Oncological Analyses
This study is working on a new way to read the genetic information related to cancer, which could help doctors find important details about your cancer and create better, personalized treatment plans just for you.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Electronic Biosciences, INC. NIH-funded |
| Lab location | 1 site (San Diego, United States) |
| Project ID | NIH-11006600 on NIH RePORTER |
What this research studies
This research focuses on developing a new sequencing technology that uses nanopore-based methods to analyze cancer-related genomic variations. By improving the accuracy of sequencing, especially in complex regions of the genome that are often overlooked, this approach aims to provide a more comprehensive understanding of cancer genetics. The methodology involves detecting genomic variations on a single molecule basis, which allows for longer reads and better context of the genetic information. This could lead to more effective cancer screening and personalized treatment options in the future.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with a history of cancer or those at high risk for developing cancer due to genetic factors.
Not a fit: Patients with non-genetic forms of cancer or those who do not have a family history of cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could enable more accurate and accessible cancer screening, leading to earlier detection and better treatment outcomes for patients.
How similar studies have performed: Previous research has shown promise in using nanopore sequencing for genomic analysis, indicating potential for success in this novel approach.
Where this research is happening
San Diego, United States
- Electronic Biosciences, INC. — San Diego, United States (Active)
Researchers
- Principal investigator: Peterson, Eric Mayo — Electronic Biosciences, INC.
- Study coordinator: Peterson, Eric Mayo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.